Stock Quote Recent News February 26, 2026 News Release Generate Biomedicines, Inc. Announces Pricing of Initial Public Offering View On: PRNewswire January 29, 2026 News Release Generate:Biomedicines Welcomes Aarif Khakoo, MD, MBA, as Chief Scientific Officer View On: Generate:Biomedicines December 01, 2025 News Release Generate:Biomedicines to Initiate Global Phase 3 Studies of GB-0895, a Long-Acting Anti-TSLP Antibody for Severe Asthma Engineered with AI View On: Generate:Biomedicines September 25, 2025 News Release Generate:Biomedicines to Present Phase 1 Results for AI-Engineered GB-0895 in Asthma at the European Respiratory Society International Congress View On: Generate:Biomedicines
